WO2018150392A1 - Prothèse atrio-ventriculaire à flux asymétrique - Google Patents
Prothèse atrio-ventriculaire à flux asymétrique Download PDFInfo
- Publication number
- WO2018150392A1 WO2018150392A1 PCT/IB2018/051026 IB2018051026W WO2018150392A1 WO 2018150392 A1 WO2018150392 A1 WO 2018150392A1 IB 2018051026 W IB2018051026 W IB 2018051026W WO 2018150392 A1 WO2018150392 A1 WO 2018150392A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- leaflet
- prosthesis
- plane
- prosthesis according
- atrio
- Prior art date
Links
- 230000017531 blood circulation Effects 0.000 claims abstract 2
- 210000005240 left ventricle Anatomy 0.000 claims description 9
- 210000004115 mitral valve Anatomy 0.000 claims description 8
- 230000037431 insertion Effects 0.000 claims 1
- 238000003780 insertion Methods 0.000 claims 1
- 230000002861 ventricular Effects 0.000 description 4
- 239000012530 fluid Substances 0.000 description 3
- 210000003709 heart valve Anatomy 0.000 description 3
- 238000007914 intraventricular administration Methods 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 2
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027727 Mitral valve incompetence Diseases 0.000 description 1
- 208000033774 Ventricular Remodeling Diseases 0.000 description 1
- 210000001765 aortic valve Anatomy 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000005265 energy consumption Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000018578 heart valve disease Diseases 0.000 description 1
- 230000000004 hemodynamic effect Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000004975 mitral orifice Anatomy 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000003540 papillary muscle Anatomy 0.000 description 1
- 230000021715 photosynthesis, light harvesting Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 210000003102 pulmonary valve Anatomy 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/04—Hollow or tubular parts of organs, e.g. bladders, tracheae, bronchi or bile ducts
- A61F2/06—Blood vessels
- A61F2002/068—Modifying the blood flow model, e.g. by diffuser or deflector
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0037—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in height or in length
Definitions
- the left ventricle (LV) is the strongest chamber in the human heart that pumps blood to provide oxygen and nutrients to tissues and in the whole body.
- the intraventricular circulation is a consequence of the asymmetry of the mitral orifice with respect to the ventricular chamber, where the eccentric inflow gives rise to an asymmetric rotatory motion that accompanies the redirection of the rapid flow entering from the mitral valve toward the opposite facing outflow tract. Therefore, the fluid dynamics trough the native mitral valve is characterized by the presence of intraventricular vortex which plays a central role in the global synchronicity of the beating heart.
- fluid dynamics inside the LV is little or no use in clinical and are not taken into account for the design of prosthetic valves.
- Asymmetric functional component Different number, shape and size of leaflets can be arranged so as to produce an asymmetric flow. This feature can be achieved by mounting a tissue valve with different leaflet sizes based on the unequal placement of the commissures. With at least two different sizes of tissue leaflets supported by a more posterior commissure, the opening can be modulated so as the flow can be directed towards the LV posterior wall i.e., modulating the angle between the annular attachment and the commissure may be different being the larger leaflet having a greater angle and the smaller leaflet a lesser angle.
- a bileaflet prosthesis may have the larger leaflet (that corresponds anatomically to the anterior mitral leaflet) covering more than 50% of the surface. Consequently, in this way, it is possible to achieve an asymmetric flow similar to the flow of the native valve.
- the valve is assembled as a standard multileaflet valvular prosthesis.
- the design, shape and size of the leaflets may be symmetric, what changes is the plane of closure of the leaflets regarding the inter-annular plan. All mitral bioprosthesis surgically implanted have the plane of closure of the leaflets at the same level of the interannular plane.
- a not aligned axis is created between the plane of closure of the leaflets and the inter-annular plane.
- the central flow typical of this type of prosthesis is then directed to the posterior wall of the ventricle, consequently allowing the formation of an asymmetric (not central) intraventricular flow.
- This solution can be applied also for mechanical prosthesis.
- Figure 1 a (prior art) Symmetric bileaflet prosthesis mounted in a stent frame S, anterior leaflet (AL) and posterior leaflet (PL). With this design, the leaflet's coaptation C occurs in the middle of the stent frame.
- FIG. 3 Example of a trileaflet prosthesis according to the invention.
- the plane of closure of the trileaflets a-a is oblique to the interannular plane a-a'. Therefore, the transvalvular flow F generated is asymmetric similar to the native valve.
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Abstract
La prothèse atrio-ventriculaire à feuillets multiples est caractérisée par le fait qu'elle est conçue pour induire un flux sanguin asymétrique.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IBPCT/IB2017/050957 | 2017-02-20 | ||
IB2017050957 | 2017-02-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2018150392A1 true WO2018150392A1 (fr) | 2018-08-23 |
Family
ID=61683843
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2018/051026 WO2018150392A1 (fr) | 2017-02-20 | 2018-02-20 | Prothèse atrio-ventriculaire à flux asymétrique |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2018150392A1 (fr) |
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11039919B2 (en) | 2017-10-31 | 2021-06-22 | W. L. Gore & Associates, Inc. | Valved conduit |
US11351058B2 (en) | 2017-03-17 | 2022-06-07 | W. L. Gore & Associates, Inc. | Glaucoma treatment systems and methods |
US11419717B2 (en) | 2017-06-29 | 2022-08-23 | Open Stent Solution Sas | Intraluminal support structure and prosthetic valve for the same |
USD977642S1 (en) | 2018-10-29 | 2023-02-07 | W. L. Gore & Associates, Inc. | Pulmonary valve conduit |
US11617644B2 (en) | 2014-10-13 | 2023-04-04 | W. L. Gore & Associates, Inc. | Prosthetic valved conduit |
US11678983B2 (en) | 2018-12-12 | 2023-06-20 | W. L. Gore & Associates, Inc. | Implantable component with socket |
US12239573B2 (en) | 2018-08-29 | 2025-03-04 | W. L. Gore & Associates, Inc. | Drug therapy delivery systems and methods |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013160439A1 (fr) * | 2012-04-27 | 2013-10-31 | Epygon Sasu | Prothèse de valvule cardiaque |
US20160113764A1 (en) * | 2014-06-11 | 2016-04-28 | Medtronic Vascular, Inc. | Prosthetic Valve With Flow Director |
WO2016178126A1 (fr) * | 2015-05-05 | 2016-11-10 | The Medical Research Infrastructure And Health Services Fund Of The Tel-Aviv Medical Center | Implant de valve atrio-ventriculaire gauche |
-
2018
- 2018-02-20 WO PCT/IB2018/051026 patent/WO2018150392A1/fr active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013160439A1 (fr) * | 2012-04-27 | 2013-10-31 | Epygon Sasu | Prothèse de valvule cardiaque |
US20160113764A1 (en) * | 2014-06-11 | 2016-04-28 | Medtronic Vascular, Inc. | Prosthetic Valve With Flow Director |
WO2016178126A1 (fr) * | 2015-05-05 | 2016-11-10 | The Medical Research Infrastructure And Health Services Fund Of The Tel-Aviv Medical Center | Implant de valve atrio-ventriculaire gauche |
Non-Patent Citations (1)
Title |
---|
PEDRIZZETTI G ET AL.: "On the Left Ventricular Vortex Reversal after Mitral Valve Replacement", ANNALS OF BIOMEDICAL ENGINEERING, vol. 38, 2010, pages 769 - 773, XP019786061 |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11617644B2 (en) | 2014-10-13 | 2023-04-04 | W. L. Gore & Associates, Inc. | Prosthetic valved conduit |
US11351058B2 (en) | 2017-03-17 | 2022-06-07 | W. L. Gore & Associates, Inc. | Glaucoma treatment systems and methods |
US11406533B2 (en) | 2017-03-17 | 2022-08-09 | W. L. Gore & Associates, Inc. | Integrated aqueous shunt for glaucoma treatment |
US11523940B2 (en) | 2017-03-17 | 2022-12-13 | W. L. Gore & Associates, Inc. | Delivery aids for glaucoma shunts |
US12150897B2 (en) | 2017-03-17 | 2024-11-26 | W. L. Gore & Associates, Inc. | Delivery aids for glaucoma shunts |
US11419717B2 (en) | 2017-06-29 | 2022-08-23 | Open Stent Solution Sas | Intraluminal support structure and prosthetic valve for the same |
US11039919B2 (en) | 2017-10-31 | 2021-06-22 | W. L. Gore & Associates, Inc. | Valved conduit |
US12186182B2 (en) | 2017-10-31 | 2025-01-07 | Edwards Lifesciences Corporation | Valved conduit |
US12239573B2 (en) | 2018-08-29 | 2025-03-04 | W. L. Gore & Associates, Inc. | Drug therapy delivery systems and methods |
USD977642S1 (en) | 2018-10-29 | 2023-02-07 | W. L. Gore & Associates, Inc. | Pulmonary valve conduit |
US11678983B2 (en) | 2018-12-12 | 2023-06-20 | W. L. Gore & Associates, Inc. | Implantable component with socket |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2018150392A1 (fr) | Prothèse atrio-ventriculaire à flux asymétrique | |
US7455689B2 (en) | Four-leaflet stented mitral heart valve | |
EP2991584B1 (fr) | Valves prosthétiques | |
EP2073755B1 (fr) | Cadre de montage intra-annulaire pour réparation de valve aortique | |
US4759759A (en) | Bubble heart valve | |
EP1610722B1 (fr) | Appareil de retablissement de la fonction aortique valvulaire et procede de traitement utilisant cet appareil | |
CN101605511B (zh) | 大小逐渐变化的瓣环成形术环 | |
US5163953A (en) | Toroidal artificial heart valve stent | |
US20050228494A1 (en) | Controlled separation heart valve frame | |
JP2016067931A (ja) | 心臓弁逆流を治療するための埋め込み型デバイス | |
AU2005206914A1 (en) | Devices and methods for repairing cardiac valves | |
WO2014201384A1 (fr) | Valve mitrale transcathéter | |
EP3960128A1 (fr) | Prothèse de valve cardiaque | |
JP5392539B2 (ja) | ステントレス人工僧帽弁及び人工弁葉 | |
Barratt-Boyes et al. | The stentless bioprosthesis: surgical challenges and implications for long-term durability | |
US20250114192A1 (en) | Valve skirts for prosthetic devices | |
Relland et al. | The third generation Carpentier-Edwards bioprosthesis: early results | |
US20220304801A1 (en) | Prosthetic heart valve | |
CN204909723U (zh) | 一种人工生物心脏瓣膜成形环 | |
Kim et al. | Aortic valve leaflet replacement with bovine pericardium to preserve native dynamic capabilities of the aortic annulus | |
WO2025001474A1 (fr) | Stent pour prothèse de valvule, et prothèse de valvule | |
AU2011235960B2 (en) | Devices and methods for repairing cardiac valves | |
Bronzino et al. | Cardiac Valve Prostheses | |
UA123570U (uk) | Кільце для анулопластики мітрального клапана | |
Ribeiro et al. | Reconstructive surgery for aortic valve disease |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18711687 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 18711687 Country of ref document: EP Kind code of ref document: A1 |